JAK Monotherapy Shows Efficacy in RA Review - Top-Institutions - MDSpire

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

  • By

  • Andrea Surnit

  • May 22, 2026

  • 4 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Sligo University Hospital
    Sligo University Hospital

    Sligo, Ireland

    Key Differentiators

    • Rheumatology

  • #2

    CorEvitas RA registry
    CorEvitas RA registry

    Not specified, Not specified

    Key Differentiators

    • Rheumatology

  • #3

    Nagoya University Hospital
    Nagoya University Hospital

    Nagoya, Japan

    Key Differentiators

    • Rheumatology

  • #4

    New England Independent Review
    New England Independent Review

    Not specified, Not specified

    Key Differentiators

    • Rheumatology

Original Source(s)

JAK Monotherapy Shows Efficacy in RA Review

  • by Andrea Surnit

  • May 22, 2026

Related Content

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation

Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies